Daunorubicin Liposomal Dosage
Medically reviewed on September 29, 2017.
Applies to the following strengths: 2 mg/mL
Usual Adult Dose for:
Additional dosage information:
Usual Adult Dose for Kaposi's Sarcoma
For first line cytotoxic therapy for advanced HIV-associated Kaposi's sarcoma. (Note: Daunorubicin liposomal is not recommended for use in patients with less than advanced HIV-related Kaposi's sarcoma.
If the patient has an acceptable benefit-cardiac risk ratio and adequate blood cell counts, then the recommended dose is: 40 mg/m2 infused intravenously over 60 minutes every 2 weeks,
Renal Dose Adjustments
If the serum creatinine is >3 mg/dL, then 1/2 of the normal dose is recommended
Liver Dose Adjustments
If the serum bilirubin is 1.2 to 3 mg/dL, then 3/4 of the normal dose is recommended.
If the serum bilirubin is >3 mg/dL, then 1/2 of the normal dose is recommended
Safety has not been established in patients with pre-existing renal or hepatic dysfunction.
More about daunorubicin liposomal
- Daunorubicin liposomal Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Drug class: antibiotics/antineoplastics
Other brands: DaunoXome